Data / AI leaders

BRCA Care Cannot Start at Diagnosis

AI Improved Sepsis Compliance. Patients Still Need the Outcome Proof.

BMI is not enough. Cardiometabolic risk is hiding in where fat lives

AI genomics market set to hit $9.3B by 2030, but regulation and equity gaps remain unresolved

Precision cardiology is becoming the new oncology. Policy and reimbursement must catch up

Could AI help prevent the next athlete cardiac tragedy? Evidence is moving faster than practice

Cancer Sequencing Becomes the Operating System of Precision Oncology

AI Pathology Starts Moving Toward Treatment Selection

AI Multiomics Moves Into the Trial Stratification Layer
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
